2 terminated, 1 not yet recruiting, 1 recruiting. 3 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Terminated 2, Recruiting 1 |
| Phase 1 | 1 | Not yet recruiting 1 |
Follow Systemic Sclerosis With Lung Involvement: new trials by email Literature Review of Systemic Sclerosis With Lung Involvement trials Research Report on Systemic Sclerosis With Lung Involvement
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| C-CAR168, an Autologous Anti-CD20/BCMA Chimeric Antigen Receptor T-Cell Therapy, in Participants With Systemic Sclerosis (SSc) Refractory to Standard Therapy C-CAR168 - Systemic Sclerosis (SSc), Systemic Sclerosis | Phase 1 | Not yet recruiting | AbelZeta Inc. | 12 | 2027-03-01 | 2026-10-13 |
| Mycophenolate Mofetil in Systemic Sclerosis With Subclinical Interstitial Lung Disease Mycophenolate Mofetil, Placebo - Systemic Sclerosis With Lung Involvement, Systemic Sclerosis | Phase 2 | Recruiting | Centre hospitalier de l'Université de Montréal (CHUM) | 35 | 2024-08-29 | 2026-09-29 |
| A Study Evaluating the Efficacy and Safety of Vixarelimab in Participants With Idiopathic Pulmonary Fibrosis and in Participants With Systemic Sclerosis-Associated Interstitial Lung Disease Vixarelimab, Placebo - Idiopathic Pulmonary Fibrosis, Systemic Sclerosis With Lung Involvement | Phase 2 | Terminated | Genentech, Inc. | 286 | 2023-05-26 | 2026-02-09 |
| A Study to Evaluate the Safety and Tolerability of Oral Ixazomib in Scleroderma-related Lung Disease Patients Ixazomib - Systemic Sclerosis, Scleroderma | Phase 2 | Terminated | Michael M. Pham | 4 | 2021-04-28 | 2025-04-06 |
Scleroderma, Systemic (3) · Lung Diseases, Interstitial (2) · Scleroderma, Diffuse (2) · Autoimmune Diseases (1) · Idiopathic Pulmonary Fibrosis (1) · Pulmonary Fibrosis (1)
Connective Tissue Diseases (3) · Lung Diseases (3) · Respiratory Tract Diseases (3) · Skin Diseases (3) · Skin and Connective Tissue Diseases (3) · Fibrosis (1) · Immune System Diseases (1) · Lung Diseases, Interstitial (1) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1) · Pulmonary Fibrosis (1)
Mycophenolic Acid (1) · ixazomib (1)
AbelZeta Inc. (1) · Centre hospitalier de l'Université de Montréal (CHUM) (1) · Genentech, Inc. (1) · Michael M. Pham (1)
United States (3) · Canada (2) · Argentina (1) · Australia (1) · Belgium (1) · Brazil (1) · Chile (1) · France (1) · Germany (1) · Greece (1) · Israel (1) · Italy (1) · Mexico (1) · New Zealand (1) · Poland (1)
Michael Pham, MD (1) · Sabrina Hoa, MD (1) · Yihong Yao, PhD (1)